Coegin Pharma AS agreed to acquire GoldBlue AB (publ) (NGM:GOLDB) in a reverse merger transaction for SEK 53.9 million on July 30, 2020. Under the terms of transaction, the purchase price of SEK 30 million will be paid through set off issue through which Coegin Pharma AB will become the majority owner of GoldBlue AB.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.8 SEK | -2.86% | +0.59% | +26.28% |
05-23 | Coegin Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-02 | Coegin Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+26.28% | 10.24M | |
+19.41% | 45.51B | |
-8.62% | 38.52B | |
+38.65% | 38.13B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- COEGIN Stock
- News Coegin Pharma AB
- Coegin Pharma AS agreed to acquire GoldBlue AB in a reverse merger transaction for SEK 53.9 million.